Targeted imaging and therapy of prostate cancer by radionuclide labeled small molecule inhibitors of prostate specific membrane antigen / 中华核医学与分子影像杂志
Chinese Journal of Nuclear Medicine and Molecular Imaging
;
(6): 53-58, 2018.
Article
in Chinese
| WPRIM
| ID: wpr-708815
ABSTRACT
Prostate specific membrane antigen (PSMA) overexpresses in most prostate cancer (PCa) lesions and plays an important role in the early diagnosis and preoperative staging,clinical decision making,recurrence and metastasis detection as well as targeted therapy.Radionuclide (especially 68Ga and 177Lu) labeled multiple small molecule inhibitors of PSMA have been wildly used in SPECT,PET imaging on PCa,and play an important role in the treatment of metastatic castration resistant prostate cancer (mCRPC).This review summarizes the development in these fields.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
/
Screening study
Language:
Chinese
Journal:
Chinese Journal of Nuclear Medicine and Molecular Imaging
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS